145 related articles for article (PubMed ID: 34799230)
21. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
22. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis.
Kwakman JJM; Bond MJG; Demichelis RM; Koopman M; Hompes R; Elferink MAG; Punt CJA
Eur J Cancer; 2024 Jan; 197():113466. PubMed ID: 38061213
[TBL] [Abstract][Full Text] [Related]
24. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
[TBL] [Abstract][Full Text] [Related]
25. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
[TBL] [Abstract][Full Text] [Related]
26. Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.
Bushati M; Pucciarelli S; Gennaro N; Maretto I; Toppan P; Perin A; Urso EDL; Bagatella A; Spolverato G
Int J Colorectal Dis; 2019 Dec; 34(12):2129-2136. PubMed ID: 31724079
[TBL] [Abstract][Full Text] [Related]
27. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.
Wibe A; Møller B; Norstein J; Carlsen E; Wiig JN; Heald RJ; Langmark F; Myrvold HE; Søreide O;
Dis Colon Rectum; 2002 Jul; 45(7):857-66. PubMed ID: 12130870
[TBL] [Abstract][Full Text] [Related]
28. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
[TBL] [Abstract][Full Text] [Related]
29. Practice patterns and long-term survival for early-stage rectal cancer.
Stitzenberg KB; Sanoff HK; Penn DC; Meyers MO; Tepper JE
J Clin Oncol; 2013 Dec; 31(34):4276-82. PubMed ID: 24166526
[TBL] [Abstract][Full Text] [Related]
30. Cancer of the upper rectum.
Bondeven P
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697137
[TBL] [Abstract][Full Text] [Related]
31. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
[TBL] [Abstract][Full Text] [Related]
32. [Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study].
Hoch J; Ferko A; Bláha M; Ryška A; Čapov I; Dušek L; Feit J; Grega M; Hermanová M; Hovorková E; Chmelová R; Kala Z; Klos D; Kodet R; Langer D; Hadži-Nikolov D; Örhalmi J; Páral J; Tichý M; Tučková I; Vjaclovský M; Vlček P
Rozhl Chir; 2016; 95(7):262-71. PubMed ID: 27523174
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
Tokunaga T; Nishi M; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Bando Y; Shimada M
Anticancer Res; 2017 Oct; 37(10):5617-5622. PubMed ID: 28982878
[TBL] [Abstract][Full Text] [Related]
34. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
35. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
[TBL] [Abstract][Full Text] [Related]
36. Towards personalized treatment of T2N0 rectal cancer: A systematic review of long-term oncological outcomes of neoadjuvant therapy followed by local excision.
Peltrini R; Imperatore N; Di Nuzzo MM; Pellino G
J Gastroenterol Hepatol; 2022 Aug; 37(8):1426-1433. PubMed ID: 35614027
[TBL] [Abstract][Full Text] [Related]
37. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
39. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.
Callender GG; Das P; Rodriguez-Bigas MA; Skibber JM; Crane CH; Krishnan S; Delclos ME; Feig BW
Ann Surg Oncol; 2010 Feb; 17(2):441-7. PubMed ID: 19847569
[TBL] [Abstract][Full Text] [Related]
40. Is local excision an appropriate treatment modality in patients presenting with early-stage (cT1 N0 M0) rectal adenocarcinoma?
Roat-Shumway S; Tonelli C; Singer M; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
Surgery; 2023 Mar; 173(3):665-673. PubMed ID: 36273975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
